Dual Trajectories of Antiretroviral Therapy Adherence and Polypharmacy in Women with HIV in the United States

[1]  K. Anastos,et al.  Degree of polypharmacy and cognitive function in older women with HIV. , 2022, AIDS research and human retroviruses.

[2]  P. Tien,et al.  Polypharmacy Is Associated With Falls in Women With and Without HIV , 2022, Journal of acquired immune deficiency syndromes.

[3]  Ying Xie,et al.  Polypharmacy, Medication-Related Burden and Antiretroviral Therapy Adherence in People Living with HIV Aged 50 and Above: A Cross-Sectional Study in Hunan, China , 2022, Patient preference and adherence.

[4]  M. Danjuma,et al.  What is polypharmacy in people living with HIV/AIDS? A systematic review , 2021, AIDS Research and Therapy.

[5]  Cecile D. Lahiri,et al.  Sex Differences in Non-AIDS Comorbidities Among People With Human Immunodeficiency Virus , 2021, Open forum infectious diseases.

[6]  L. Menéndez-Arias,et al.  Update and latest advances in antiretroviral therapy. , 2021, Trends in pharmacological sciences.

[7]  O. Mgbere,et al.  Evaluation of the Sociodemographic, Behavioral and Clinical Influences on Complete Antiretroviral Therapy Adherence Among HIV-Infected Adults Receiving Medical Care in Houston, Texas , 2021, HIV/AIDS.

[8]  I. Wilson,et al.  Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States. , 2020, AIDS.

[9]  D. Holdford,et al.  Medication Adherence Trajectories: A Systematic Literature Review , 2020, Journal of managed care & specialty pharmacy.

[10]  L. McKnight-Eily,et al.  Alcohol use among HIV-positive women of childbearing age, United States, 2013–2014 , 2020, AIDS care.

[11]  K. Bennett,et al.  Mapping the use of Group-Based Trajectory Modelling in medication adherence research: A scoping review protocol , 2020, HRB open research.

[12]  Mardge H. Cohen,et al.  Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy , 2020, BMC Women's Health.

[13]  C. Marzolini,et al.  Polypharmacy and drug-drug interactions in HIV-infected subjects in the region of Madrid, Spain: a population-based study. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  C. Okoli,et al.  Relationship Between Polypharmacy and Quality of Life Among People in 24 Countries Living With HIV , 2020, Preventing chronic disease.

[15]  A. Adimora,et al.  The Prevalence and Burden of Non-AIDS Comorbidities among Women living with or at-risk for HIV Infection in the United States. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  C. Marzolini,et al.  The challenge of HIV treatment in an era of polypharmacy , 2020, Journal of the International AIDS Society.

[17]  F. Palella,et al.  Examination of Polypharmacy Trajectories Among HIV-Positive and HIV-Negative Men in an Ongoing Longitudinal Cohort from 2004 to 2016. , 2019, AIDS patient care and STDs.

[18]  M. Mugavero,et al.  The State of Adherence to HIV Care in Black Women , 2018, The Journal of the Association of Nurses in AIDS Care : JANAC.

[19]  Gina Wingood,et al.  Cohort Profile: The Women's Interagency HIV Study (WIHS). , 2018, International journal of epidemiology.

[20]  J. D. de Wit,et al.  Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy , 2017, AIDS.

[21]  C. B. Hare,et al.  A Pharmacist‐Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV‐Positive Patients , 2017, Pharmacotherapy.

[22]  Blair T. Johnson,et al.  Behavioral Interventions Targeting Alcohol Use Among People Living with HIV/AIDS: A Systematic Review and Meta-Analysis , 2017, AIDS and Behavior.

[23]  S. Perera,et al.  Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program , 2016, Journal of General Internal Medicine.

[24]  C. Almeida-González,et al.  Concurrent Use of Comedications Reduces Adherence to Antiretroviral Therapy Among HIV-Infected Patients , 2014, Journal of managed care & specialty pharmacy.

[25]  J. Glover,et al.  The Next Therapeutic Challenge in HIV: Polypharmacy , 2013, Drugs & Aging.

[26]  Danijela Gnjidic,et al.  Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. , 2012, Journal of clinical epidemiology.

[27]  Daniel S. Nagin,et al.  A Note on a Stata Plugin for Estimating Group-based Trajectory Models , 2012 .

[28]  Daniel S Nagin,et al.  Group-based trajectory modeling in clinical research. , 2010, Annual review of clinical psychology.

[29]  J. Rehm,et al.  Causal considerations on alcohol and HIV/AIDS--a systematic review. , 2010, Alcohol and alcoholism.

[30]  Ann E. Kurth,et al.  Self-Report Measures of Antiretroviral Therapy Adherence: A Review with Recommendations for HIV Research and Clinical Management , 2006, AIDS and Behavior.

[31]  M. Young,et al.  The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench , 2005, Clinical Diagnostic Laboratory Immunology.

[32]  Joseph Feldman,et al.  The Women's Interagency HIV Study , 1998 .

[33]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[34]  L. Radloff.  The CES-D Scale , 1977 .

[35]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[36]  L. Radloff.  The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .